| Primary |
| Infection Prophylaxis |
15.7% |
| Antibiotic Prophylaxis |
10.2% |
| Preoperative Care |
9.3% |
| Dermatitis Atopic |
8.3% |
| Gingivitis |
8.3% |
| Anaesthesia |
7.4% |
| Surgery |
6.5% |
| Prophylaxis |
5.6% |
| Anti-infective Therapy |
3.7% |
| Antibiotic Therapy |
2.8% |
| Bacterial Infection |
2.8% |
| Mucosal Inflammation |
2.8% |
| Postoperative Wound Infection |
2.8% |
| Systemic Lupus Erythematosus |
2.8% |
| Alveolar Osteitis |
1.9% |
| Dental Plaque |
1.9% |
| Drug Administration Error |
1.9% |
| Periodontitis |
1.9% |
| Product Used For Unknown Indication |
1.9% |
| Therapeutic Procedure |
1.9% |
|
| Anaphylactic Reaction |
20.3% |
| Transmission Of An Infectious Agent Via A Medicinal Product |
8.9% |
| Pharmaceutical Product Complaint |
7.6% |
| Urticaria |
7.6% |
| Burkholderia Cepacia Complex Infection |
5.1% |
| Product Contamination |
5.1% |
| Product Quality Issue |
5.1% |
| Sputum Culture Positive |
5.1% |
| Circulatory Collapse |
3.8% |
| Documented Hypersensitivity To Administered Drug |
3.8% |
| Swollen Tongue |
3.8% |
| Tachycardia |
3.8% |
| Bronchospasm |
2.5% |
| Caustic Injury |
2.5% |
| Drug Hypersensitivity |
2.5% |
| Erythema |
2.5% |
| Glossodynia |
2.5% |
| Incorrect Route Of Drug Administration |
2.5% |
| Latex Allergy |
2.5% |
| Rash |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
30.8% |
| Anaesthesia |
13.2% |
| Systemic Lupus Erythematosus |
12.0% |
| Surgery |
6.1% |
| Prophylaxis |
5.9% |
| Anaesthesia Procedure |
4.2% |
| General Anaesthesia |
3.8% |
| Antibiotic Prophylaxis |
3.1% |
| Maternal Exposure During Pregnancy |
2.8% |
| Drug Exposure During Pregnancy |
2.6% |
| Skin Test Negative |
2.4% |
| Drug Use For Unknown Indication |
2.1% |
| Induction Of Anaesthesia |
1.9% |
| Infection Prophylaxis |
1.9% |
| Acanthamoeba Keratitis |
1.6% |
| Cellulitis |
1.4% |
| Nerve Block |
1.4% |
| Aneurysm Repair |
0.9% |
| Hypertension |
0.9% |
| Occupational Exposure To Drug |
0.9% |
|
| Anaphylactic Reaction |
18.8% |
| Teratogenicity |
12.9% |
| Tachycardia |
9.4% |
| Urticaria |
7.1% |
| Hypotension |
5.9% |
| Maternal Drugs Affecting Foetus |
5.9% |
| Drug Exposure During Pregnancy |
4.7% |
| Pharmaceutical Product Complaint |
4.7% |
| Anaphylactic Shock |
3.5% |
| Blood Pressure Decreased |
3.5% |
| Cytolytic Hepatitis |
3.5% |
| Hypersensitivity |
3.5% |
| Blood Pressure Abnormal |
2.4% |
| Circulatory Collapse |
2.4% |
| Corneal Erosion |
2.4% |
| Rash |
2.4% |
| Syncope |
2.4% |
| Urinary Tract Infection |
2.4% |
| Cardiac Arrest |
1.2% |
| Cardio-respiratory Arrest |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.3% |
| Drug Use For Unknown Indication |
25.6% |
| Multiple Myeloma |
5.9% |
| Pain |
5.1% |
| Prophylaxis |
3.1% |
| Metastases To Bone |
3.1% |
| Hypertension |
2.6% |
| Nausea |
2.6% |
| Breast Cancer |
2.5% |
| Adverse Event |
1.8% |
| Depression |
1.8% |
| Acute Myeloid Leukaemia |
1.7% |
| Constipation |
1.6% |
| Osteoporosis |
1.5% |
| Anxiety |
1.4% |
| Prostate Cancer |
1.2% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Diffuse Large B-cell Lymphoma |
1.0% |
| Neoplasm Malignant |
1.0% |
| Acute Lymphocytic Leukaemia |
1.0% |
|
| Weight Decreased |
18.4% |
| Vomiting |
13.9% |
| Tooth Extraction |
8.5% |
| Wound Drainage |
5.6% |
| Weight Increased |
5.4% |
| Thrombocytopenia |
5.0% |
| Urinary Tract Infection |
5.0% |
| Pyrexia |
4.9% |
| Toothache |
4.0% |
| White Blood Cell Count Decreased |
3.6% |
| Wheezing |
3.5% |
| Wheelchair User |
3.3% |
| Pulmonary Embolism |
3.0% |
| Pain |
2.8% |
| Renal Failure Acute |
2.4% |
| Respiratory Failure |
2.4% |
| Sepsis |
2.4% |
| White Blood Cell Count Increased |
2.1% |
| Pneumonia |
1.9% |
| Tooth Fracture |
1.9% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
| Keratitis |
50.0% |
| Pharyngeal Oedema |
50.0% |
|
